Responses
Clinical/translational cancer immunotherapy
Original research
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study
Compose a Response to This Article
Other responses
No responses have been published for this article.
